Email ID : 
Password : 
Forgot Your Password ? 

Only Report Titles
Titles & Keywords
NOTE: Site best viewed with Internet Explorer
  VETERINARY VACCINES
A Global Strategic Business Report

This report analyzes the worldwide markets for Veterinary Vaccines in US$ Million. The specific product segments analyzed are Companion Animal Vaccines (Canine Vaccines, & Feline Vaccines), and Livestock Vaccines (Porcine Vaccines, Bovine Vaccines, Poultry Vaccines, Ovine Vaccines, Equine Vaccines, & Other Animal Vaccines). The report provides separate comprehensive analytics for the US, Europe and Rest of World. Annual forecasts are provided for the period of 2000 through 2015. The report profiles 64 companies including many key and niche players worldwide such as AVANT Immunotherapeutics, Inc., Megan Health, Inc., Bayer HealthCare AG, Biogenesis-Bago, Fort Dodge Animal Health, Heska Corporation, Imugene Limited, Merial Animal Health Ltd., Pfizer, Inc., Embrex, Inc., Protein Sciences Corporation, Schering-Plough Corporation, Intervet International B.V. , Intervet, Inc., and Virbac Corporation. Market data and analytics are derived from primary and secondary research. Company profiles are mostly extracted from URL research and reported select online sources.

CODE:    MCP-1129  PAGES:    368
PRICE:    $3950  DATE:       May 2008
COMPANIES:  64  MARKET DATA TABLES:   125
Due to the proprietary nature, our previews are offered only to manufacturers, top-tier management consultants, investment banks, and investment research groups.

 TABLE OF CONTENTS  
  VETERINARY VACCINES (Complete Report) Pages : 368   | $3950
I. INTRODUCTION, METHODOLOGY & PRODUCT DEFINITIONS5$100
   Study Reliability and Reporting Limitations.....I-1  
   Disclaimers.....I-2
Data Interpretation & Reporting Level.....I-2
  
   Quantitative Techniques & Analytics.....I-3
Product Definitions and Scope of Study.....I-3
A. Companion Animal Vaccines.....I-3
  
   B. Livestock Vaccines.....I-4
Porcine Vaccines.....I-4
Bovine Vaccines.....I-4
Poultry Vaccines.....I-4
Ovine Vaccines.....I-4
Equine Vaccines.....I-4
  
   Other Animal Vaccines.....I-5  
II. EXECUTIVE SUMMARY74$2250
  1. Industry Overview & Outlook.....II-13 $600  
   Global Animal Health Care Industry - A Brief Review.....II-1
Table 1: Global Animal Health Products Market by Region (2007): Percentage Share Breakdown by Value Sales for Europe, North America, Latin America and Rest of World (includes corresponding Graph/Chart).....II-1
1$350
   Table 2: Global Animal Health Products Market by Product Group (2007): Percentage Share Breakdown by Value sales for Parasiticides, Vaccines, Anti-Infectives, Medical Feed Additives and Other Pharmaceuticals (includes corresponding Graph/Chart).....II-2
Scope of the Report.....II-2
Current And Future Analysis.....II-2
2$500
  2. Market Trends & Issues.....II-42 $200  
   Companion Animal Vaccines: Trailing on a High Growth Track.....II-4
OTC Market: A Potential Threat for Veterinarians.....II-4
Parasiticides, Systemic Agents To Drive The Market.....II-4
Taxonomy of Vaccines.....II-4
Bird Flu – The Aftermath.....II-4
1$100
   Vaccination – Critical for Controlling Avian Influenza Virus.....II-5
1$100
  3. Product Overview.....II-610 $700  
   Vaccines - An Evolutionary Scan.....II-6
Contribution of Animal Research to Vaccine Production.....II-6
1$100
   Veterinary Medicines- A Brief Review.....II-7
Preventive Medicines.....II-7
Therapeutic Medicines.....II-7
Others.....II-7
Veterinary Vaccines – An Essential Component of Animal Health Care.....II-7
1$100
   What Does A Veterinary Vaccine Do?.....II-8
Classification of Veterinary Vaccines.....II-8
Companion Animal Vaccines.....II-8
Canine Vaccines.....II-8
2$200
   Feline Vaccines.....II-101$100
   Livestock Vaccines.....II-11
Bovine Vaccines.....II-11
1$100
   Poultry Vaccines.....II-12
Ovine Vaccines.....II-12
Porcine Vaccines.....II-12
1$100
   Equine Vaccines.....II-13
Aquaculture Vaccines.....II-13
A Tabular Analysis on Select Animal Diseases Controlled by Vaccines.....II-13
1$100
   Vaccination and Its Reactions.....II-14
Veterinary Vaccines- Latest Breakthroughs.....II-14
Marker vaccines.....II-14
DNA vaccines.....II-14
Gene-deleted vaccines.....II-14
Viral-vectored vaccines.....II-14
2$200
  4. Notes on Select Animal Diseases.....II-163 $300  
   Brucellosis.....II-16
Tuberculosis.....II-16
Johne’s disease.....II-16
Spirochete Associated Diseases.....II-16
Respiratory Disease in Goats, Sheep, and Cattle.....II-16
1$100
   Porcine Respiratory Diseases.....II-17
Mastitis .....II-17
African Swine Fever.....II-17
Avian Influenza.....II-17
1$100
   East Coast Fever.....II-18
Hemorrhagic Septicemia.....II-18
Foot-And-Mouth Disease.....II-18
Japanese Encephalitis.....II-18
Rift Valley Fever.....II-18
1$100
  5. Product Innovations/Introductions.....II-195 $500  
   Intervet Develops Bluetongue Vaccine.....II-19
Agroinsuvet Introduces New Vaccines .....II-19
Merial Rolls Out Vaxxitek® HVT+IBD Hatchery Vaccine for Poultry Industry.....II-19
Intervet & FLI Develop Dual Vaccine Prototype for Birds.....II-19
Schering-Plough Receives USDA License for its Rhusigen™ Erysipelas Vaccine.....II-19
1$100
   USDA Approves Use of PreveNile™ Vaccine for Horses.....II-20
Fort Dodge Animal Health Develops Reverse Genetics Avian Vaccine.....II-20
Boehringer Ingelheim’s Swine Vaccine Gains Approval in Australia.....II-20
Merial Limited Gets USDA Approval for DNA Vaccine for Melanoma in Dogs.....II-20
1$100
   Embrex’s Poultry Vaccine Inovocox Gets USDA Approval.....II-21
Skystar Bio-Pharmaceutical Develops Avian Influenza Vaccine.....II-21
USDA Grants Conditional License for Necrotic Enteritis Vaccine.....II-21
Fort Dodge Receives USDA License for Pyramid®10.....II-21
1$100
   USDA Licenses Use of Fort Dodge’s Suvaxyn® PCV2 Vaccine in Pigs.....II-22
USDA Grants Conditional License to Pfizer’s New Canine Vaccine.....II-22
Continuum ™ DAP Vaccine from Intervet.....II-22
1$100
   Lohmann Unveils Vaccine for Gumboro Disease.....II-23
New Vaccine for Bovine Respiratory Disease.....II-23
Corpoica & Limor Introduce Cattle Vaccine.....II-23
Chiron to Roll Out Rabies Vaccine in China.....II-23
Heska Launches Feline UltraNasal(TM) Vaccines.....II-23
Merial Unveils Two PUREVAX® Respiratory Vaccines.....II-23
1$100
  6. Recent Industry Activity.....II-2411 $800  
   Bayer Inks Agreement with Juvaris.....II-24
Pfizer Inks Agreement with IVT.....II-24
Vivalis Extends Research Collaboration with Kaketsuken.....II-24
Merial Bags Major Australian Contract.....II-24
USDA Approves Intervet Vaccine.....II-24
Merial Pockets Ancare.....II-24
1$100
   Heska Revises Distribution Agreement with AgriLabs.....II-25
Animal Health International Acquires Kane Veterinary.....II-25
Industrial Equity Investments Pockets Arysta LifeScience.....II-25
Henry Schein Acquires W&J Dunlop.....II-25
Tecnovax Establishes New Facility.....II-25
Pingtung Agricultural to Set Up an Exclusive Veterinary Park.....II-25
1$100
   Ouro Fino To Expand Veterinary Product Suite.....II-26
Alpharma Acquires Yantai Jinhai.....II-26
Pfizer Animal Health Acquires Embrex.....II-26
Schering-Plough Acquires Intervet.....II-26
Schering-Plough Acquires Organon.....II-26
1$100
   Intervet Sets Up New Animal Vaccine Production Facility in Boxmeer.....II-27
Crucell Licenses PER.C6® Technology to Pfizer Animal Health.....II-27
CVRL to Synthesize New Animal Vaccines.....II-27
Pfizer to Shut Down Omaha Animal Vaccine Center.....II-27
1$100
   IGI Inc Licenses Novasomes to Novavax.....II-28
IPB Collaborates with Shigeta for Vaccine Production.....II-28
Suguna Poultry Steps into Livestock Vaccine Production Business.....II-28
European Medicines Agency Grants Community Authorization for Nobilis Influenza
  H7N1.....II-28
1$100
   AVANT & Pfizer Collaborate to Develop Animal Vaccines.....II-29
Intervet Acquires FMD Vaccine Production Facility from Bayer Healthcare.....II-29
CFIA Authorizes Bioniche E. Coli O157: H7 Cattle Vaccine for Field Use.....II-29
1$100
   Hemispherx Biopharma Acquires DOGS Molecule Patent .....II-30
Hind Industries to Establish Animal Vaccine Formulations Plant at Patiala.....II-30
Cryosite and Animal Health Australia Form Partnership.....II-30
Hester Pharmaceuticals Plans Capacity Expansion.....II-30
Biovet Pvt Ltd to Set up Animal Vaccine Plant in Karnataka.....II-30
IPB and Shigeta Establish JV for Production of CLOSE 5.1 Vaccine.....II-30
IPB Shigeta Acquires Bird Flu Vaccine Rights from MedImmune.....II-30
1$100
   Bioject Signs Three Agreements With Merial.....II-31
PetCARE signs US distribution agreement with Butler Animal Health Supply.....II-31
Poultry Vaccine to be produced in Vladimir.....II-31
DEFRA Against Vaccine Usage For Bird Flu.....II-31
Butler & Burns Complete Business Merger.....II-31
1$100
   Ivax Completes Phoenix Scientific’s Acquisition.....II-32
Crucell Signs Licensing Agreement with Merial.....II-32
Charlesbank Acquires Walco.....II-32
Imugene Signs an Agreement with Abic Biological.....II-32
Vical Licenses Core Technology to Merial.....II-32
1$100
   Pfizer Acquires CSL’s Veterinary Vaccines Business.....II-33
Antigenics Sells Feline Leukemia Vaccine Unit.....II-33
Embrex Establishes Novel In Ovo Vaccine Plant.....II-33
Indian Immunological Bags Order for Foot and Mouth Disease Vaccine.....II-33
Crucell Issues West Nile Virus Vaccine License to Pfizer.....II-33
1$100
   Kimron Veterinary Signs a License Agreement with Crucell.....II-34
Akzo Constructs Manufacturing Unit in Boxmeer.....II-34
1$100
  7. Research and Development.....II-358 $600  
   Scientists Develop New Vaccine Against Disease Related to PCV2.....II-35
Auburn University and Vaxin Researchers Develop Avian Flu Vaccine.....II-35
UK Researchers Develop In-Shell Vaccine for Chicks.....II-35
1$100
   Researchers in Vietnam Decode the H5N1 Virus Gene.....II-36
Pittsburgh Researchers Create Avian Flu Vaccine from H5N1 Virus.....II-36
University of Warwick Develops Protecting Virus Method.....II-36
1$100
   New Treatment Measure Against Ovine Salmonella & Brucellosis.....II-37
ICAR Develops Indigenous Bird Flu Vaccine.....II-37
St. Jude Develops Flu Virus Vaccine through Reverse Genetics.....II-37
Researchers Develop Vaccine for Swine Disease.....II-37
1$100
   Researchers Develop Experimental Vaccine Against 1918 Influenza Virus.....II-38
Study Proves Effectiveness of Intradermal Vaccine Administration in Rabbits.....II-38
CEL-SCI’s CEL-1000 Peptide Shows Adjuvant Activity.....II-38
1$100
   Progress in Vaccine for Canine Cancer.....II-39
Vaccine for Avian Flu Developed.....II-39
Vector for DNA Vaccine Developed.....II-39
Bovine Herpesvirus 1 VP22Improves the Efficiency of DNA Vaccine.....II-39
1$100
   Vaccine Against Canine Flu Underway.....II-40
Study on Immunity in Dogs.....II-40
New Sheep Vaccine in Clinical Trials.....II-40
1$100
   Commercialization of Poultry Vaccine Underway.....II-41
Vaccine for B. Anthracis Developed.....II-41
Efficacy of E.Coli 0157 Vaccine Demonstrated.....II-41
1$100
   Calgary-based Biotechnology Company to develop Oral Vaccine for Cattle Against
  Pneumonia.....II-42
Vaccine for Tick-Borne Disease Underway.....II-42
Feline Immunodeficiency Virus Rhinotracheitis Vaccine for Cats Under Trials.....II-42
Japanese Study on Bird Flu Vaccine.....II-42
1$100
  8. Focus on Select Global Players.....II-435 $500  
   AVANT Immunotherapeutics, Inc (USA).....II-43
Megan Health, Inc. (USA).....II-43
Bayer HealthCare AG (Germany).....II-43
Biogenesis-Bago (Argentina).....II-43
1$100
   Fort Dodge Animal Health (USA).....II-44
Heska Corporation (USA).....II-44
Imugene Limited (Australia).....II-44
1$100
   Merial Animal Health Ltd. (UK).....II-45
Pfizer, Inc. (USA).....II-45
Embrex, Inc. (USA).....II-45
Protein Sciences Corporation (USA).....II-45
1$100
   Schering-Plough Corporation (USA).....II-46
Intervet International B.V. (The Netherlands).....II-46
1$100
   Intervet, Inc. (USA).....II-47
Virbac Corporation (USA).....II-47
1$100
  9. Global Market Perspective.....II-48   
   Table 3: World Recent Past, Current & Future Analysis for Veterinary Vaccines by Geographic Region – US, Europe and Rest of World Markets Independently Analyzed with Annual Sales Figures in US$ Million for Years 2000 through 2010 (includes corresponding Graph/Chart).....II-481$350
   Table 4: World Long-term Projections for Veterinary Vaccines by Geographic Region – US, Europe and Rest of World Markets Independently Analyzed with Annual Sales Figures in US$ Million for Years 2011 through 2015 (includes corresponding Graph/Chart).....II-49

Table 5: World 10-Year Perspective for Veterinary Vaccines by Geographic Region – Percentage Breakdown of Dollar Sales for US, Europe and Rest of World Markets for Years 2003, 2008 & 2012 (includes corresponding Graph/Chart).....II-49
1$350
   Table 6: World Recent Past, Current & Future Analysis for Companion Animal Vaccines by Geographic Region – US, Europe and Rest of World Markets Independently Analyzed with Annual Sales Figures in US$ Million for Years 2000 through 2010 (includes corresponding Graph/Chart).....II-501$350
   Table 7: World Long-term Projections for Companion Animal Vaccines by Geographic Region – US, Europe and Rest of World Markets Independently Analyzed with Annual Sales Figures in US$ Million for Years 2011through 2015 (includes corresponding Graph/Chart).....II-51

Table 8: World 10-Year Perspective for Companion Animal Vaccines by Geographic Region – Percentage Breakdown of Dollar Sales for US, Europe and Rest of World Markets for Years 2003, 2008 & 2012 (includes corresponding Graph/Chart).....II-51
1$350
   Table 9: World Recent Past, Current & Future Analysis for Companion Animal Vaccines by Product Segment- Canine Vaccines & Feline Vaccines Markets Independently Analyzed with Annual Sales Figures in US$ Million for Years 2000 through 2010 (includes corresponding Graph/Chart).....II-52

Table 10: World Long-term Projections for Companion Animal Vaccines by Product Segment- Canine Vaccines & Feline Vaccines Markets Independently Analyzed with Annual Sales Figures in US$ Million for Years 2011 through 2015 (includes corresponding Graph/Chart).....II-52
1$350
   Table 11: World 10-Year Perspective for Companion Animal Vaccines by Product Segment – Percentage Breakdown of Dollar Sales for Canine Vaccines & Feline Vaccines Markets for Years 2003, 2008 & 2012.....II-531$350
   Table 12: World Recent Past, Current & Future Analysis for Canine Vaccines by Geographic Region – US, Europe and Rest of World Markets Independently Analyzed with Annual Sales Figures in US$ Million for Years 2000 through 2010 (includes corresponding Graph/Chart).....II-541$350
   Table 13: World Long-term Projections for Canine Vaccines by Geographic Region – US, Europe and Rest of World Markets Independently Analyzed with Annual Sales Figures in US$ Million for Years 2011 through 2015(includes corresponding Graph/Chart).....II-55

Table 14: World 10 – Year Perspective for Canine Vaccines by Geographic region – Percentage Breakdown of Dollar Sales for US, Europe and Rest of World Markets for Years 2003, 2008 & 2012 (includes corresponding Graph/Chart).....II-55
1$350
   Table 15: World Recent Past, Current & Future Analysis for Feline Vaccines by Geographic Region – US, Europe and Rest of World Markets Independently Analyzed with Annual Sales Figures in US$ Million for Years 2000 through 2010 (includes corresponding Graph/Chart).....II-561$350
   Table 16: World Long-term Projections for Feline Vaccines by Geographic Region – US, Europe and Rest of World Markets Independently Analyzed with Annual Sales Figures in US$ Million for Years 2011 through 2015(includes corresponding Graph/Chart).....II-57

Table 17: World 10 – Year Perspective for Feline Vaccines by Geographic Region – Percentage Breakdown of Dollar Sales for US, Europe and Rest of World Markets for Years 2003, 2008 & 2012 (includes corresponding Graph/Chart).....II-57
1$350
   Table 18: World Recent Past, Current & Future Analysis for Livestock Vaccines by Geographic Region – US, Europe and Rest of World Markets Independently Analyzed with Annual Sales Figures in US$ Million for Years 2000 through 2010 (includes corresponding Graph/Chart).....II-581$350
   Table 19: World Long-term Projections for Livestock Vaccines by Geographic Region – US, Europe and Rest of World Markets Independently Analyzed with Annual Sales Figures in US$ Million for Years 2011 through 2015 (includes corresponding Graph/Chart).....II-59

Table 20: World 10 – Year Perspective for Livestock Vaccines by Geographic Region – Percentage Breakdown of Dollar Sales for US, Europe and Rest of World Markets for Years 2003, 2008 & 2012 (includes corresponding Graph/Chart).....II-59
1$350
   Table 21: World Recent Past, Current & Future Analysis for Livestock Vaccines by Product Segment – Porcine Vaccines, Bovine Vaccines, Poultry Vaccines, Ovine Vaccines, Equine Vaccines & Other Animal Vaccines Markets Independently Analyzed with Annual Sales Figures in US$ Million for Years 2000 through 2010 (includes corresponding Graph/Chart).....II-601$350
   Table 22: World Long-term Projections for Livestock Vaccines by Product Segment – Porcine Vaccines, Bovine Vaccines, Poultry Vaccines, Ovine Vaccines, Equine Vaccines & Other Animal Vaccines Markets Independently Analyzed with Annual Sales Figures in US$ Million for Years 2011 through 2015(includes corresponding Graph/Chart).....II-611$350
   Table 23: World 10-Year Perspective for Livestock Vaccines by Product Segment – Percentage Breakdown of Dollar Sales for Porcine Vaccines, Bovine Vaccines, Poultry Vaccines, Ovine Vaccines, Equine Vaccines & Other Animal Vaccines Markets for Years 2003, 2008 & 2012 (includes corresponding Graph/Chart).....II-621$350
   Table 24: World Recent Past, Current & Future Analysis for Porcine Vaccines by Geographic Region – US, Europe and Rest of World Markets Independently Analyzed with Annual Sales Figures in US$ Million for Years 2000 through 2010 (includes corresponding Graph/Chart).....II-631$350
   Table 25: World Long-term Projections for Porcine Vaccines by Geographic Region – US, Europe and Rest of World Markets Independently Analyzed with Annual Sales Figures in US$ Million for Years 2011 through 2015(includes corresponding Graph/Chart).....II-64

Table 26: World 10 – Year Perspective for Porcine Vaccines by Geographic region – Percentage Breakdown of Dollar Sales for US, Europe and Rest of World Markets for Years 2003, 2008 & 2012 (includes corresponding Graph/Chart).....II-64
1$350
   Table 27: World Recent Past, Current & Future Analysis for Bovine Vaccines by Geographic Region – US, Europe and Rest of World Markets Independently Analyzed with Annual Sales Figures in US$ Million for Years 2000 through 2010 (includes corresponding Graph/Chart).....II-651$350
   Table 28: World Long-term Projections for Bovine Vaccines by Geographic Region – US, Europe and Rest of World Markets Independently Analyzed with Annual Sales Figures in US$ Million for Years 2011 through 2015 (includes corresponding Graph/Chart).....II-66

Table 29: World 10 – Year Perspective for Bovine Vaccines by Geographic region – Percentage Breakdown of Dollar Sales for US, Europe and Rest of World Markets for Years 2003, 2008 & 2012 (includes corresponding Graph/Chart).....II-66
1$350
   Table 30: World Recent Past, Current & Future Analysis for Poultry Vaccines by Geographic Region – US, Europe and Rest of World Markets Independently Analyzed with Annual Sales Figures in US$ Million for Years 2000 through 2010 (includes corresponding Graph/Chart).....II-671$350
   Table 31: World Long-term Projections for Poultry Vaccines by Geographic Region – US, Europe and Rest of World Markets Independently Analyzed with Annual Sales Figures in US$ Million for Years 2011 through 2015 (includes corresponding Graph/Chart).....II-68

Table 32: World 10 – Year Perspective for Poultry Vaccines by Geographic region – Percentage Breakdown of Dollar Sales for US, Europe and Rest of World Markets for Years 2003, 2008 & 2012 (includes corresponding Graph/Chart).....II-68
1$350
   Table 33: World Recent Past, Current & Future Analysis for Ovine Vaccines by Geographic Region – US, Europe and Rest of World Markets Independently Analyzed with Annual Sales Figures in US$ Million for Years 2000 through 2010 (includes corresponding Graph/Chart).....II-691$350
   Table 34: World Long-term Projections for Ovine Vaccines by Geographic Region – US, Europe and Rest of World Markets Independently Analyzed with Annual Sales Figures in US$ Million for Years 2011 through 2015(includes corresponding Graph/Chart).....II-70

Table 35: World 10 – Year Perspective for Ovine Vaccines by Geographic region – Percentage Breakdown of Dollar Sales for US, Europe and Rest of World Markets for Years 2003, 2008 & 2012 (includes corresponding Graph/Chart).....II-70
1$350
   Table 36: World Recent Past, Current & Future Analysis for Equine Vaccines by Geographic Region – US, Europe and Rest of World Markets Independently Analyzed with Annual Sales Figures in US$ Million for Years 2000 through 2010 (includes corresponding Graph/Chart).....II-711$350
   Table 37: World Long-term Projections for Equine Vaccines by Geographic Region – US, Europe and Rest of World Markets Independently Analyzed with Annual Sales Figures in US$ Million for Years 2011 through 2015 (includes corresponding Graph/Chart).....II-72

Table 38: World 10 – Year Perspective for Equine Vaccines by Geographic region – Percentage Breakdown of Dollar Sales for US, Europe and Rest of World Markets for Years 2003, 2008 & 2012 (includes corresponding Graph/Chart).....II-72
1$350
   Table 39: World Recent Past, Current & Future Analysis for Other Animal Vaccines by Geographic Region – US, Europe and Rest of World Markets Independently Analyzed with Annual Sales Figures in US$ Million for Years 2000 through 2010 (includes corresponding Graph/Chart).....II-731$350
   Table 40: World Long-term Projections for Other Animal Vaccines by Geographic Region – US, Europe and Rest of World Markets Independently Analyzed with Annual Sales Figures in US$ Million for Years 2011 through 2015(includes corresponding Graph/Chart).....II-74

Table 41: World 10 – Year Perspective for Other Animal Vaccines by Geographic region – Percentage Breakdown of Dollar Sales for US, Europe and Rest of World Markets for Years 2003, 2008 & 2012 (includes corresponding Graph/Chart).....II-74
1$350
III. MARKET59$1950
  1. The United States.....III-115 $1175  
   A. Market Analysis.....III-1
Current & Future Analysis.....III-1
H5N1 Virus: A Conundrum for the US Industry.....III-1
Rabies Cases in the US (2005).....III-1
1$75
   Historic Data.....III-2
Table 42: Leading Players in the US Rabies Vaccines Market (1995): Percentage Market Share for Pfizer, Fort Dodge, Solvay, Rhone Merieux and Others (includes corresponding Graph/Chart).....III-2
Strategic Developments.....III-2
4$800
   Product Launches/ Developments.....III-63$225
   Key US Players.....III-9
AVANT Immunotherapeutics, Inc (USA).....III-9
Megan Health Inc......III-9
Fort Dodge Animal Health.....III-9
1$75
   Heska Corporation.....III-10
Intervet, Inc......III-10
Pfizer Inc.....III-10
1$75
   Embrex, Inc.....III-11
Protein Sciences Corporation.....III-11
Schering-Plough Corporation.....III-11
1$75
   Virbac Corporation.....III-121$75
   B. Market Analytics.....III-13
Table 43: US Recent Past, Current & Future Analysis for Veterinary Vaccines by Product Group/Segment – Companion Animal Vaccines (Canine & Feline Vaccines), Livestock Vaccines (Porcine Vaccines, Bovine Vaccines, Poultry Vaccines, Ovine Vaccines, Equine Vaccines & Other Animal Vaccines) Markets Independently Analyzed with Annual Sales Figures in US$ Million for Years 2000 through 2010 (includes corresponding Graph/Chart).....III-13
1$200
   Table 44: US Long-term Projections for Veterinary Vaccines by Product Group/Segment – Companion Animal Vaccines (Canine & Feline Vaccines), Livestock Vaccines (Porcine Vaccines, Bovine Vaccines, Poultry Vaccines, Ovine Vaccines, Equine Vaccines & Other Animal Vaccines) Markets Independently Analyzed with Annual Sales Figures in US$ Million for Years 2011 through 2015(includes corresponding Graph/Chart).....III-141$200
   Table 45: US 10-Year Perspective for Veterinary Vaccines by Product Group/Segment – Percentage Breakdown of Dollar Sales for Companion Animal Vaccines (Canine Vaccines & Feline Vaccines), Livestock Vaccines (Porcine Vaccines, Bovine Vaccines, Poultry Vaccines, Ovine Vaccines, Equine Vaccines & Other Animal Vaccines) Markets for 2003, 2008 & 2012 (includes corresponding Graph/Chart).....III-15
1$200
  2. Europe.....III-167 $825  
   A. Market Analysis.....III-16
Current & Future Analysis.....III-16
By Segment.....III-16
Strategic Development.....III-16
1$75
   B. Market Analytics.....III-17
Table 46: European Recent Past, Current & Future Analysis for Veterinary Vaccines by Geographic Region – France, Germany, Italy, United Kingdom and Rest of Europe Markets Independently Analyzed with Annual Sales Figures in US$ Million for Years 2000 through 2010 (includes corresponding Graph/Chart).....III-17
1$200
   Table 47: European Long-term Projections for Veterinary Vaccines by Geographic Region – France, Germany, Italy, United Kingdom and Rest of Europe Markets Independently Analyzed with Annual Sales Figures in US$ Million for Years 2011 through 2015 (includes corresponding Graph/Chart).....III-181$200
   Table 48: European 10-Year Perspective for Veterinary Vaccines by Geographic Region – Percentage Breakdown of Dollar Sales for France, Germany, Italy, United Kingdom and Rest of Europe for Years 2003, 2008 & 2012 (includes corresponding Graph/Chart).....III-191$200
   Table 49: European Recent Past, Current & Future Analysis of Veterinary Vaccines by Product Group/Segment – Companion Animal Vaccines (Canine Vaccines and Feline Vaccines) and Livestock Vaccines (Porcine Vaccines, Bovine Vaccines, Poultry Vaccines, Ovine Vaccines, Equine Vaccines & Other Animal Vaccines) Markets Independently Analyzed with Annual Sales Figures in US$ Million for Years 2000 through 2010 (includes corresponding Graph/Chart).....III-201$200
   Table 50: European Long-term Projections for Veterinary Vaccines by Product Group/Segment – Companion Animal Vaccines (Canine & Feline Vaccines), Livestock Vaccines (Porcine Vaccines, Bovine Vaccines, Poultry Vaccines, Ovine Vaccines, Equine Vaccines & Other Animal Vaccines) Markets Independently Analyzed with Annual Sales Figures in US$ Million for Years 2011 through 2015(includes corresponding Graph/Chart).....III-211$200
   Table 51: European 10 – Year Perspective for Veterinary Vaccines by Product Group/Segment – Companion Animal Vaccines (Canine Vaccines and Feline Vaccines) and Livestock Vaccines (Porcine Vaccines, Bovine Vaccines, Poultry Vaccines, Ovine Vaccines, Equine Vaccines and Other Animal Vaccines) Markets for Years 2003, 2008 & 2012 (includes corresponding Graph/Chart).....III-22
1$200
  2a. France.....III-234 $425  
   A. Market Analysis.....III-23
Current & Future Analysis.....III-23
Strategic Development.....III-23
1$75
   B. Market Analytics.....III-24
Table 52: French Recent Past, Current & Future Analysis for Veterinary Vaccines by Product Group/Segment – Companion Animal Vaccines (Canine Vaccines & Feline Vaccines), Livestock Vaccines (Porcine Vaccines, Bovine Vaccines, Poultry Vaccines, Ovine Vaccines & Equine Vaccines) Markets Independently Analyzed with Annual Sales Figures in US$ Million for Years 2000 through 2010 (includes corresponding Graph/Chart).....III-24
1$200
   Table 53: French Long-term Projections for Veterinary Vaccines by Product Group/Segment – Companion Animal Vaccines (Canine & Feline Vaccines), Livestock Vaccines (Porcine Vaccines, Bovine Vaccines, Poultry Vaccines, Ovine Vaccines, & Equine Vaccines) Markets Independently Analyzed with Annual Sales Figures in US$ Million for Years 2011 through 2015 (includes corresponding Graph/Chart).....III-251$200
   Table 54: French 10-Year Perspective for Veterinary Vaccines by Product Group/Segment – Percentage Breakdown of Dollar Sales for Companion Animal Vaccines (Canine Vaccines & Feline Vaccines), Livestock Vaccines (Porcine Vaccines, Bovine Vaccines, Poultry Vaccines, Ovine Vaccines & Equine Vaccines) Markets for 2003, 2008 & 2012 (includes corresponding Graph/Chart).....III-26
1$200
  2b. Germany.....III-274 $425  
   A. Market Analysis.....III-27
Current & Future Analysis.....III-27
Strategic Developments.....III-27
1$75
   Key German Players.....III-28
Bayer HealthCare AG.....III-28
B. Market Analytics.....III-28
Table 55: German Recent Past, Current & Future Analysis for Veterinary Vaccines by Product Group/ Segment – Companion Animal Vaccines (Canine Vaccines & Feline Vaccines), Livestock Vaccines (Porcine Vaccines, Bovine Vaccines, Poultry Vaccines, Ovine Vaccines & Equine Vaccines) Markets Independently Analyzed with Annual Sales Figures in US$ Million for Years 2000 through 2010 (includes corresponding Graph/Chart).....III-28
1$200
   Table 56: German Long-term Projections for Veterinary Vaccines by Product Group/Segment – Companion Animal Vaccines (Canine & Feline Vaccines), Livestock Vaccines (Porcine Vaccines, Bovine Vaccines, Poultry Vaccines, Ovine Vaccines, & Equine Vaccines) Markets Independently Analyzed with Annual Sales Figures in US$ Million for Years 2011 through 2015 (includes corresponding Graph/Chart).....III-291$200
   Table 57: German 10-Year Perspective for Veterinary Vaccines by Product Group/Segment – Percentage Breakdown of Dollar Sales for Companion Animal Vaccines (Canine Vaccines & Feline Vaccines), Livestock Vaccines (Porcine Vaccines, Bovine Vaccines, Poultry Vaccines, Ovine Vaccines & Equine Vaccines) Markets for 2003, 2008 & 2012 (includes corresponding Graph/Chart).....III-30
1$200
  2c. Italy.....III-313 $375  
   Market Analysis.....III-31
Table 58: Italian Recent Past, Current & Future Analysis for Veterinary Vaccines by Product Group/Segment – Companion Animal Vaccines (Canine Vaccines & Feline Vaccines), Livestock Vaccines (Porcine Vaccines, Bovine Vaccines, Poultry Vaccines, Ovine Vaccines, Equine Vaccines & Other Animal Vaccines) Markets Independently Analyzed with Annual Sales Figures in US$ Million for Years 2000 through 2010 (includes corresponding Graph/Chart).....III-31
1$200
   Table 59: Italian Long-term Projections for Veterinary Vaccines by Product Group/Segment – Companion Animal Vaccines (Canine & Feline Vaccines), Livestock Vaccines (Porcine Vaccines, Bovine Vaccines, Poultry Vaccines, Ovine Vaccines, Equine Vaccines & Other Animal Vaccines) Markets Independently Analyzed with Annual Sales Figures in US$ Million for Years 2011 through 2015 (includes corresponding Graph/Chart).....III-321$200
   Table 60: Italian 10-Year Perspective for Veterinary Vaccines by Product Group/Segment – Percentage Breakdown of Dollar Sales for Companion Animal Vaccines (Canine Vaccines & Feline Vaccines), Livestock Vaccines (Porcine Vaccines, Bovine Vaccines, Poultry Vaccines, Ovine Vaccines, Equine Vaccines & Other Animal Vaccines) Markets for 2003, 2008 & 2012 (includes corresponding Graph/Chart).....III-33
1$200
  2d. The United Kingdom.....III-345 $475  
   A. Market Analysis.....III-34
Current & Future Analysis.....III-34
Strategic Corporate Developments.....III-34
Product Launches.....III-34
1$75
   Key Player in UK.....III-35
Merial Animal Health Ltd.....III-35
1$75
   B. Market Analytics.....III-36
Table 61: UK Recent Past, Current & Future Analysis for Veterinary Vaccines by Product Group/Segment – Companion Animal Vaccines (Canine Vaccines & Feline Vaccines), Livestock Vaccines (Porcine Vaccines, Bovine Vaccines, Poultry Vaccines, Ovine Vaccines, Equine Vaccines & Other Animal Vaccines) Markets Independently Analyzed with Annual Sales Figures in US$ Million for Years 2000 through 2010 (includes corresponding Graph/Chart).....III-36
1$200
   Table 62: UK Long-term Projections for Veterinary Vaccines by Product Group/Segment – Companion Animal Vaccines (Canine & Feline Vaccines), Livestock Vaccines (Porcine Vaccines, Bovine Vaccines, Poultry Vaccines, Ovine Vaccines, Equine Vaccines & Other Animal Vaccines) Markets Independently Analyzed with Annual Sales Figures in US$ Million for Years 2011 through 2015 (includes corresponding Graph/Chart).....III-371$200
   Table 63: UK 10-Year Perspective for Veterinary Vaccines by Product Group/Segment – Percentage Breakdown of Dollar Sales for Companion Animal Vaccines (Canine Vaccines & Feline Vaccines), Livestock Vaccines (Porcine Vaccines, Bovine Vaccines, Poultry Vaccines, Ovine Vaccines, Equine Vaccines &Other Animal Vaccines) Markets for 2003, 2008 & 2012 (includes corresponding Graph/Chart).....III-38
1$200
  2e. Rest of Europe.....III-398 $600  
   A. Market Analysis.....III-39
Overview.....III-39
A Note on Danish Veterinary Services.....III-39
1$75
   The 2002 Standards of Danish Medicines recommend test for antibody inducing
  fragments in veterinary vaccines.....III-40
Hungary Vaccinates Birds Across Zoos.....III-40
Russia Mass-Produces Vaccines Against Avian Flu.....III-40
1$75
   Product Launches/Developments.....III-41
Strategic Developments.....III-41
2$150
   Focus on Select Players.....III-43
Intervet International B.V. (The Netherlands).....III-43
1$75
   B. Market Analytics.....III-44
Table 64: Rest of Europe Recent Past, Current & Future Analysis for Veterinary Vaccines – by Product Group/ Segment for Companion Animal Vaccines (Canine Vaccines & Feline Vaccines), Livestock Vaccines (Porcine Vaccines, Bovine Vaccines, Poultry Vaccines, Ovine Vaccines, Equine Vaccines & Other Animal Vaccines) Markets Independently Analyzed with Annual Sales Figures in US$ Million for Years 2000 through 2010 (includes corresponding Graph/Chart).....III-44
1$200
   Table 65: Rest of Europe Long-term Projections for Veterinary Vaccines by Product Group/Segment – Companion Animal Vaccines (Canine & Feline Vaccines), Livestock Vaccines (Porcine Vaccines, Bovine Vaccines, Poultry Vaccines, Ovine Vaccines, Equine Vaccines & Other Animal Vaccines) Markets Independently Analyzed with Annual Sales Figures in US$ Million for Years 2011 through 2015(includes corresponding Graph/Chart).....III-451$200
   Table 66: Rest of Europe 10-Year Perspective for Veterinary Vaccines by Product/Segment – Percentage Breakdown of Dollar Sales for Companion Animal Vaccines (Canine Vaccines & Feline Vaccines), Livestock Vaccines (Porcine Vaccines, Bovine Vaccines, Poultry Vaccines, Ovine Vaccines, Equine Vaccines & Other Animal Vaccines) Markets for 2003, 2008 & 2012 (includes corresponding Graph/Chart).....III-46
1$200
  3. Rest of World.....III-4713 $825  
   A. Market Analysis.....III-47
Overview.....III-47
Focus on Select Regions.....III-47
Canada.....III-47
Overview of Canadian Animal Health Industry.....III-47
Import and Manufacture of Veterinary Biologics.....III-47
1$75
   First to Access E. coli 0157: H7 Vaccine.....III-48
China.....III-48
An Emerging Veterinary Vaccine Hub.....III-48
China Initiates Mass Vaccination Campaign Against Bird Flu Virus.....III-48
1$75
   Australia.....III-49
A Note on Australian Veterinary Therapeutics Market.....III-49
India.....III-49
ICAR Develops Indigenous Bird Flu Vaccine.....III-49
Thailand.....III-49
Japan & Thailand to Cooperate for Developing Bird Flu Vaccine.....III-49
Malaysia.....III-49
Malaysia Initiates Measures to Deal with Potential Flu Pandemic.....III-49
1$75
   Kazakhstan.....III-50
Kazakhstan Takes Proactive Measures Against Bird Flu.....III-50
North Korea.....III-50
North Korea Develops Bird Flu Vaccine.....III-50
Vietnam.....III-50
Vietnam to Mass-Produce Bird Flu Vaccines.....III-50
Vietnam Imports Bird Flu Vaccine from Russia.....III-50
Egypt.....III-50
Egypt Reports H5N1 Infection in Vaccinated Flocks.....III-50
Kenya.....III-50
Kenya to Mass-Manufacture Vaccines Against Rift Valley Fever.....III-50
1$75
   Strategic Developments.....III-514$300
   Product Launches/Developments.....III-551$75
   Focus on Select players.....III-56
Biogenesis-Bago (Argentina).....II-56
Immunovaccine Technologies Inc. (Canada).....III-56
Imugene Limited (Australia).....III-56
Indian Immunologicals Ltd (India).....III-56
1$75
   B. Market Analytics.....III-57
Table 67: Rest of World Recent Past, Current & Future Analysis for Veterinary Vaccines - by Product Group/ Segment for Companion Animal Vaccines (Canine Vaccines & Feline Vaccines), Livestock Vaccines (Porcine Vaccines, Bovine Vaccines, Poultry Vaccines, Ovine Vaccines, Equine Vaccines & Other Animal Vaccines) Markets Independently Analyzed with Annual Sales Figures in US$ Million for Years 2000 through 2010 (includes corresponding Graph/Chart).....III-57
1$200
   Table 68: Rest of World Long-term Projections for Veterinary Vaccines by Product Group/Segment – Companion Animal Vaccines (Canine & Feline Vaccines), Livestock Vaccines (Porcine Vaccines, Bovine Vaccines, Poultry Vaccines, Ovine Vaccines, Equine Vaccines & Other Animal Vaccines) Markets Independently Analyzed with Annual Sales Figures in US$ Million for Years 2011 through 2015 (includes corresponding Graph/Chart).....III-581$200
   Table 69: Rest of World 10-Year Perspective for Veterinary Vaccines by Product Group/Segment – Percentage Breakdown of Dollar Sales for Companion Animal Vaccines (Canine Vaccines & Feline Vaccines), Livestock Vaccines (Porcine Vaccines, Bovine Vaccines, Poultry Vaccines, Ovine Vaccines, Equine Vaccines & Other Animal Vaccines) Markets for 2003, 2008 & 2012 (includes corresponding Graph/Chart).....III-591$200
IV. COMPETITIVE LANDSCAPE 219$995
  
Total Companies Profiled: 63 (including Divisions/Subsidiaries - 100)

Region/Country                 Players

The United States                 31
Canada                             2
Japan                              4
Europe                            33
     France                        2
     Germany                       9
     The United Kingdom            4
     Italy                         2
     Rest of Europe               16
Asia-Pacific (Excluding Japan)    24
Middle East                        5
Africa                             1
Click here to request a full table of contents and more details on this project.		  
 
 
Due to the proprietary nature, our previews are offered only to manufacturers, top-tier management consultants, investment banks, and investment research groups.

© Copyrights 2010, Global Industry Analysts, Inc., USA.